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A B S T R A C T
Background
Pressure ulcers are defined as areas “of localized damage to the skin and underlying tissue caused by pressure, shear, friction and/or the
combination of these”. Electromagnetic therapy (EMT), in which electrodes produce an electromagnetic field across the wound, may
improve healing of chronic wounds such as pressure ulcers.
Objectives
To assess the effects of EMT on the healing of pressure ulcers.
Search methods
For this update we searched the Cochrane Wounds Group Specialised Register (2 June 2010); the Cochrane Central Register of
Controlled Trials (CENTRAL) (The Cochrane Library 2010, Issue 2); Ovid MEDLINE (2007 to May Week 3 2010); Ovid EMBASE
(2007 to Week 21 2010) and EBSCO CINAHL (2007 to 1 June 2010).
Selection criteria
Randomised controlled trials comparing EMT with sham EMT or other (standard) treatment.
Data collection and analysis
For this update two review authors independently scrutinised the results of the search to identify relevant RCTs and obtained full
reports of potentially eligible studies. We made attempts to obtain missing data by contacting study authors. A second review author
checked data extraction and disagreements were resolved after discussion between review authors.
Main results
We identified no new trials for this update.Two randomised controlled trials (RCTs), involving 60 participants, at unclear risk of bias
were included in the original review. Both trials compared the use of EMT with sham EMT, although one of the trials included a
third arm in which only standard therapy was applied. Neither study found a statistically significant difference in complete healing in
people treated with EMT compared with those in the control group. In one trial that assessed percentage reduction in wound surface
area, the difference between the two groups was reported to be statistically significant in favour of EMT. However, this result should be
interpreted with caution as this is a small study and this finding may be due to chance. Additionally, the outcome, percentage reduction
in wound area, is less clinically meaningful than complete healing.
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Authors’ conclusions
The results provide no strong evidence of benefit in using EMT to treat pressure ulcers. However, the possibility of a beneficial or
harmful effect cannot be ruled out because there were only two included trials, both with methodological limitations and small numbers
of participants. Further research is recommended.
P L A I N L A N G U A G E S U M M A R Y
Electromagnetic therapy for treating pressure ulcers
Pressure ulcers (also called bed sores, decubitus ulcers or pressure sores) are sores on the skin caused by pressure or rubbing. They usually
affect immobile people on the bony parts of their bodies such as hips, heels and elbows, and take a long time to heal. Electromagnetic
therapy is not a form of radiation or heating, but uses an electromagnetic field with the aim of stimulating healing. However, the review
of trials concluded that there is no strong evidence that electromagnetic therapy helps or hinders healing of pressure ulcers.
B A C K G R O U N D
Description of the condition
According to the European Pressure Ulcer Advisory Panel
(EPUAP) and National Pressure Ulcer Advisory Panel (NPUAP),
a pressure ulcer (also known as bed sore, bed ulcer, decubitus ulcer
or pressure sore) is “an area of localized injury to the skin and/or
underlying tissue usually over a bony prominence, as a result of
pressure, or pressure in combinationwith shear” (EPUAP-NPUAP
2009). Pressure ulcers usually develop on skin that covers bony
areas such as the sacrum, heels, hips and elbows. Most often the
ulcers develop in immobile elderly people (for example, elderly
orthopaedic patients), patients with severe, acute illnesses (such as
in people in intensive care units) and in people with neurological
problems (for example, those with spinal cord injuries).
One cross-sectional European study involving five countries found
that the overall prevalence of pressure ulcers was approximately
18% of hospital patients (EPUAP 2002). In the UK, pressure ul-
cers have been recorded in 5% to 32% of patients admitted to a
District General Hospital (the precise rate depends on case-mix),
and in 4% to 7% of patients in community settings (Kaltenthaler
2001). These ulcers represent a major burden of sickness and re-
duce quality of life for patients and their carers. There is also a
considerable cost both to the patients (Clark 1994) and the health
service (Touche Ross 1993). The annual treatment cost of pressure
ulcers has been estimated to range from £1.4 to 2.1 billion, or 4%
of total healthcare expenditure in the UK (Bennett 2004).
Pressure ulcers present as a continuum of tissue damage from un-
broken skin with sustained redness after the release of pressure
(non-blanching erythema) to destruction of the muscle and bone.
The treatment of pressure ulcers has four main elements:
1. local treatment of wounds using wound dressings and other
topical applications;
2. pressure relief using beds, mattresses or cushions, and
repositioning of the patient;
3. treatment of concurrent conditions that may delay healing,
e.g. poor nutrition and infection; and
4. use of physical therapies, such as electrical stimulation,
ultrasound and laser therapy.
Description of the intervention
Recently there has been an increasing interest in the therapeutic use
of electromagnetic fields for various medical conditions, including
pressure ulcers (Markov 2007). Electromagnetic therapy (EMT),
also known as electromagnetism, bioelectricity, magneto biology,
magnetic healing and magnetic field therapy, uses electromagnetic
energy applied to the body to treat various medical conditions,
frombone and cartilage repair (Haddad 2007;Ryaby 1998) to pain
relief (Shupak 2006; Thomas 2007), wound healing (Comorosan
1993; Kenkre 1996; Stiller 1992) and relatively new applications
such as chronic musculoskeletal pain (Thomas 2007). EMT does
not use direct electrical effects or radiation, unlike other forms of
electrotherapy, but induces a field effect (Stiller 1992). A number
of devices (e.g. Diapulse®, SoffPulse®, Pulsatron®) have been
constructed todeliver a pulsed electromagnetic field (PEMF) in the
radio frequency band. The frequency of short-wavelength radio
waves ranges from 10 to 100 MHz and the frequency commonly
used in EMT is 27.12 MHz.
PEMFs are produced with an “on-off ” effect of pulsing current to
produce effects which, it has been suggested, influence many bio-
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logical processes, and thus may be useful for wound healing. The
main advantage of PEMF compared with continuous fields is that
the short duration of the pulses protects the tissues against poten-
tial damage from heat generated by continuous fields (Athanasiou
2007; Kitchen 2002).
How the intervention might work
There are several theories that explain how the PEMF may exert
its effect on tissue generation and cell proliferation in wound heal-
ing. Lee 1993 suggested that PEMFmight facilitate the migration
of electrically charged cells involved in repairing the wound area,
thereby restoring the metabolic conditions of the healing cells. It
has also been proposed that PEMF induces a tiny electrical signal
on the injured cell membrane, which initiates a series of physiolog-
ical effects that include an increase in the number of macrophages
and fibroblasts present in the wound, a reduction of the inflam-
mation and an increased deposition of collagen and fibrin, all of
which contribute to the healing process (Markoll 2003). Other
theories suggest that PEMF is associated with the production of
free radicals within cells, which mediate intracellular communica-
tion (Gordon 2007). PEMFmay exert several biological processes
involved in wound healing, but the exact mechanism is not clear.
Why it is important to do this review
There are several anecdotal reports of the beneficial effects of EMT
for chronic skin wounds, despite the lack of standardisation of
the PEMF devices in terms of type, duration, frequency, intensity
and length of exposure. A systematic review to assess the available
evidence for EMT on pressure ulcers was warranted.
O B J E C T I V E S
To assess the evidence for the effects of electromagnetic therapy
(EMT) in the healing of pressure ulcers.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included trials if the allocation of participants to the therapies
was described as randomised. There was no restriction on the basis
of language, date of trial or publication status.
Types of participants
We included studies which involved people of any age and in any
care setting, described as having a pressure ulcer. Studies which
referred to the wounds using the synonyms decubitus, bed sore
and pressure sore were also eligible for inclusion.
Types of interventions
The application of EMT to treat pressure ulcers compared with
sham EMT, no EMT or other (standard) treatments.
Types of outcome measures
Primary outcomes
Healing of pressure ulcer using measures such as:
• proportion of ulcers healed within trial period;
• rate of change in ulcer area; and
• time to complete healing.
Secondary outcomes
• Costs.
• Quality of life.
• Pain.
• Acceptability of treatment.
Search methods for identification of studies
Electronic searches
Details of the search strategy for second update of this review are
shown in Appendix 1.
For this third update of the review, we revised the search strategies
and ran searches in the following databases to find randomised
controlled trials (RCTs) of EMT:
• Cochrane Wounds Group Specialised Register (searched 2
June 2010);
• the Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2010, Issue 2);
• Ovid MEDLINE (2007 to May Week 3 2010);
• Ovid MEDLINE - In-Process & Other Non-Indexed
Citations (searched 1 June 2010);
• Ovid EMBASE (2007 to week 21 2010); and
• EBSCO CINAHL (2007 to 1 June 2010).
The following search strategy was used in the Cochrane Central
Register of Controlled Trials (CENTRAL):
#1 MeSH descriptor Electromagnetics explode all trees
#2 MeSH descriptor Electric Stimulation Therapy explode all
trees
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#3 (electromagnetic* or electrotherap*):ti,ab,kw
#4 (electric* NEXT current):ti,ab,kw
#5 ((direct or pulsed or alternating) NEXT current):ti,ab,kw
#6 (low NEXT intensity) or (low NEXT frequency):ti,ab,kw
#7 (high NEXT voltage):ti,ab,kw
#8 (“TENS” or “NMES”):ti,ab,kw
#9 (interferential NEXT therap*):ti,ab,kw
#10 (monophasic or galvanic):ti,ab,kw
#11 MeSH descriptor Diathermy explode all trees
#12 MeSH descriptor Microwaves explode all trees
#13 (diathermy or microwave*):ti,ab,kw
#14 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR
#9 OR #10 OR #11 OR #12 OR #13)
#15 MeSH descriptor Pressure Ulcer explode all trees
#16 pressure NEXT (ulcer* or sore*):ti,ab,kw
#17 decubitus NEXT (ulcer* or sore*):ti,ab,kw
#18 (bed NEXT sore*) or bedsore:ti,ab,kw
#19 (#15 OR #16 OR #17 OR #18)
#20 (#14 AND #19)
The search strategies for Ovid MEDLINE, Ovid EMBASE and
EBSCO CINAHL can be found in Appendix 2; Appendix 3 and
Appendix 4 respectively. The Ovid MEDLINE search was com-
bined with the Cochrane Highly Sensitive Search Strategy for
identifying randomised trials in MEDLINE: sensitivity- and pre-
cision-maximizing version (2008 revision); Ovid format (Lefebvre
2009). The EMBASE and CINAHL searches were combined with
the trial filters developed by the Scottish Intercollegiate Guidelines
Network (SIGN 2010). There were no restrictions on the basis of
language or date of publication.
Searching other resources
For the original review and the first update, experts in the field (e.g.
SA Cooper-Vastola) and manufacturers (Diapulse® and Elmedis-
traal®) were also contacted and asked to provide any informa-
tion they might have about unpublished studies. For this second
update we checked the reference list of the systematic review by
McGaughey 2009 for additional studies.
Data collection and analysis
Selection of studies
For this review update, two review authors independently checked
titles and abstracts of studies identified by the update search for
eligibility. We obtained full reports of articles if they appeared to
satisfy, or to potentially satisfy, the inclusion criteria. Two review
authors independently checked full papers to identify those trials
that were eligible for inclusion. Any disagreement was resolved by
discussion between the two review authors.
For the original review, titles and abstracts of studies identified by
searching theWounds Group Specialised Register were assessed by
one review author (KF) for eligibility. Full reports of articles were
obtained if they appeared to satisfy the inclusion criteria of the
initial assessment. Those rejected were checked by another review
author (NC). Full papers were checked to identify those that were
eligible for inclusion (KF). This was repeated independently by
another review author (NC) to provide verification. Any disagree-
ment was resolved by discussion.
Data extraction and management
We extracted and summarised details of the eligible studies using
a data extraction sheet. We made attempts to obtain any missing
data by contacting the trial authors.We included data from studies
published in duplicate only once. One review author undertook
data extraction and the second author checked for accuracy. We
extracted the following data:
1. design of study;
2. inclusion and exclusion criteria;
3. baseline characteristics (by treatment group);
4. intervention details;
5. outcome measures used;
6. results (by treatment group);
7. withdrawals (by treatment group); and
8. adverse effects.
Assessment of risk of bias in included studies
Two review authors independently assessed the risk of bias of the
included studies. As recommended by the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2009), we assessed the
following methodological domains:
• Sequence generation - was the method used to generate the
allocation sequence appropriate to produce comparable groups?
• Allocation sequence concealment - was the method used to
conceal the allocation sequence appropriate to prevent the
allocation being known in advance of, or during, enrolment?
• Blinding of participants, personnel and outcome assessors -
were measures used to blind study participants, personnel and
outcome assessors from knowledge of which intervention a
participant received?
• Incomplete outcome data - how complete were the
outcome data for the primary outcomes? Were drop-out rates
and reasons for withdrawal reported? Were missing data imputed
appropriately? We considered an overall completion rate of 80%
or higher as having a low risk of bias.
• Selective outcome reporting - were appropriate outcomes
reported and were any key outcomes missing?
• Other potential threats to validity (considering external
validity, e.g. relevant use of co-interventions) - what was the
funding source of each of the studies?
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We explicitly judged each of these criteria using the following
system: Yes (i.e. low risk of bias); No (i.e. high risk of bias); and
Unclear (i.e. either lack of information, or uncertainty over the
potential for bias).
Data synthesis
We combined the studies included in the review by narrative
overview with a quantitative summary of the result of similar tri-
als where appropriate. For each trial with important dichotomous
outcomes(e.g. ulcers healed - yes or no) we calculated a risk ra-
tio of healing with 95% confidence intervals (CI). Where out-
comes for continuous variables were presented as medians without
confidence intervals, standard deviations or some measure of the
precision of the result, we entered the median into the table of
Characteristics of included studies and did not use the data in data
synthesis.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
The new search for this third review update identified four addi-
tional studies (Goldin 1981; Gupta 2009; Itoh 1991; Seaborne
1996) but none met the inclusion criteria and all were added to
the Characteristics of excluded studies where reasons for exclusion
are provided.
Two studies of EMT for the treatment of pressure ulcers, involving
a total of 60 people, are included in the review (Comorosan 1993;
Salzberg 1995). The first study (Comorosan 1993) was conducted
in a social care unit in Bucharest, Romania. This study was a three-
arm study; EMT (plus standard therapy), sham EMT (plus stan-
dard therapy) and standard therapy alone. The treatment and fol-
low up was over a two to eight-week period. A total of 30 people
were recruited: 17 female and 13 male, aged from 60 to 84 years,
with Satge II (16 participants) and Stage III (14 participants) pres-
sure ulcers (the grading system used was not described). Partic-
ipants were described as randomly allocated to one of the three
groups. Twenty people received EMT (Diapulse®) therapy plus
standard therapy; five received sham EMT (Diapulse®) therapy
plus standard therapy; and five received standard therapy alone.
The EMT therapy involved local application of electromagnetic
field at a frequency of 600 pulses per second, peak power 6 (117
V, 27.12 MHz). Treatment was given for 30 minutes, twice a day.
The standard therapy involved cleansing with hydrogen peroxide
and local application of talcum powder, methylene-blue in solu-
tion and antibiotic ointment (tetracycline). The outcome assessed
was the percentage of ulcers healed within two to eight weeks.
The second study (Salzberg 1995) compared EMT with sham
EMT over a 12-week period or until healing (if this was shorter
than 12 weeks). The participants were volunteers admitted to a
Veterans’ Administration Hospital in New York and consisted of
30male hospital inpatients with spinal cord injuries (20with Stage
II and 10 with Stage III pressure ulcers). The treatment with an
electromagnetic field provided a radio frequency of 27.2MHz and
a pulse repetition rate of 80 to 600 pulses per second. This study
also gave treatment for 30 minutes twice a day. A clear definition
of the grading of the ulcers was provided by the authors: Stage II
ulcers were defined as a partial-thickness skin loss involving epi-
dermis or dermis, superificial and clinically presenting as a deep
crater, abrasion, blister or shallow crater; while Stage III were de-
fined as full-thickness skin loss involving damage or necrosis of
subcutaneous tissue extending down to, but not through, under-
lying fascia, clinically presented as a deep crater with or without
undermining of adjacent tissue. The outcomes assessed were time
to complete healing, percent change in ulcer area and proportion
of ulcers healed.
Risk of bias in included studies
The risk of bias in the included studies is summarised in Figure 1.
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Figure 1. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
Allocation
Both trials have unclear risk of bias for sequence generation and al-
location concealment. They described the allocation to treatment
groups as randomised but there was no description on how ran-
domisation was achieved. The lack of description of the allocation
process also meant that the degree of allocation concealment was
unclear.
Blinding
In judging the risk of bias for this item, we considered how sub-
jective or objective an outcome is. There are particular risks of
bias with more subjective outcomes (Higgins 2009). The two tri-
als were judged to have unclear risk of bias for blinding. Both de-
scribed how patients and investigators were blinded to EMT and
sham EMT therapy but did not provide information on the blind-
ing of the outcome assessors. In wound trials assessment of treat-
ment outcome, namely reduction in surface area, involves an ele-
ment of subjectivity (for example in judgingwhere the wound edge
lies), therefore it is important that outcome assessors are blinded.
Incomplete outcome data
In judging the risk of bias for this item, we considered whether
missing data were imputed appropriately and whether an inten-
tion-to-treat analysis was reported for the primary outcome. The
two trials were considered to have low risk of bias for incomplete
outcome data. There was no loss to follow up in Comorosan 1993
while in Salzberg 1995 the loss to follow up occurred after the
main outcome was assessed (after one week).
Selective reporting
In considering the risk of bias for selective reporting, we based our
assessment on comparing outcomes listed in the methods section
of the paper with those outcomes reported in the results section.
Both trials had unclear risk of bias for selective reporting. Out-
comes to be assessed were not listed in the methods section in
Comorosan 1993, thus it was not clear whether the trial included
all planned outcomes. In Salzberg 1995 a subset of patients with
stage II pressure ulcers less than or equal to 60 cm2 and ulcer size
more than 60 cm2 were analysed separately. Stage II and stage III
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patients were also analysed separately. These analyses were not pre-
specified in the methods section of the paper but may have been
planned.
Other potential sources of bias
Baseline ulcer area was not reported in Comorosan 1993. Salzberg
1995 reported there was no statistically significant difference for
the baseline parameters between the EMT group and the sham
group for those with Stage II pressure ulcers (total n= 20). How-
ever, the randomisation process did not provide for an even dis-
tribution of large pressure ulcers between the two groups with the
sham EMT group having larger ulcers than the EMT group. No
baseline data were provided for patients with Stage III pressure ul-
cers, therefore we were unable to judge whether theses two groups
(n=10) were comparable at the start of the study.
Effects of interventions
Proportions of ulcers healed
Two trials compared EMT with sham EMT, although the trial by
Comorosan 1993 included a third arm in which only standard
therapy was applied.
In the Comorosan 1993 trial, 17 out of 20 (85%) ulcers in the
EMT group achieved complete healing within the duration of
treatment compared with no ulcers healing in either of the other
two groups (five ulcers in each); the risk ratio (RR)was 10.00 (95%
CI 0.70 to 143.06) (Analysis 1.1; Analysis 2.1). The difference
between the groups was statistically not significant.
In the Salzberg 1995 trial, at one week three out of 10 (30%) Stage
II pressure ulcers and three out of five (60%) Stage III pressure
ulcers in the EMT group had healed, compared with none in the
shamEMTgroup (RR7.00, 95%CI 0.41 to 120.16) and (RR 7.0,
95% CI 0.45 to 108.26) respectively (Analysis 3.1). The pooled
RR for Stage II and III was 7.00 (95% CI 0.97 to 50.38) (Analysis
3.1).
The results from these two studies do not indicate a statistically
significant treatment effect associated with EMT in healing pres-
sure ulcers, however there is a great deal of uncertainty as there are
only two small studies, both at unclear risk of bias.
We did not combine the results of the two studies (Comorosan
1993; Salzberg 1995) because of the different treatment durations.
Change in ulcer area
Change in ulcer area was not assessed in Comorosan 1993.
In Salzberg 1995, the overall change in ulcer area was presented
in the discussion section of the paper. The ulcer area reduction at
one week was 77% (SD = 21%) in the EMT group and 40% (SD
= 28%) in the sham EMT group. The mean percent difference
in area reduction between the two groups was statistically signif-
icantly greater in the EMT group (RR 37%, 95% CI 17.36 to
56.64) (Analysis 4.1). However, this result should be interpreted
with caution for two reasons; firstly, this is a small study and there
is a possibility that this finding may be due to chance differences
in prognostic variables. The randomisation process did not pro-
vide for an even distribution of large pressure ulcers between the
two groups with the sham EMT group having larger ulcers than
the EMT group. In general, a change in area or volume would
give a larger percentage reduction for a smaller ulcer than for a
bigger ulcer. Subsequently, this would favour the EMT group as it
has the smallest median wound size at baseline for stage II ulcers
(baseline values for stage III ulcers were not provided). Secondly,
the risk of bias due to generation of allocation sequence, allocation
concealment and blinding of the outcome assessor was assessed as
’unclear’ due to poor reporting.
Time to complete healing
Time to complete healing was reported only for the EMT group
in one study (Comorosan 1993). Healing in Stage II ulcers was
achieved between one and four weeks (mean 3.28 weeks), while
for Stage III ulcers healing time was between two and eight weeks
(mean = 4.87). In Salzberg 1995, the median time to complete
healing was 13 days for the EMT group, compared with 31.5 days
for the sham EMT group (P value < 0.001). However, the results
of these two studies could not be combined as measures of variance
were not reported. Furthermore baseline imbalances for wound
area in Salzberg 1995 introduce bias for this outcome.
Secondary outcomes
Secondary outcomes, namely costs, quality of life, pain and ac-
ceptability of treatment were not assessed in either trial.
Adverse effects
No adverse effects were observed in Comorosan 1993, while
Salzberg 1995 did not provide information on adverse effects.
D I S C U S S I O N
There is no strong evidence from two small trials that EMT speeds
pressure ulcer healing. Both trials contained small numbers of pa-
tients and used different regimens of treatment over different time
scales. There was evidence from one trial showing that the EMT
group achievedmore reduction inwound area than the shamEMT
group. However, this result needs to be interpreted with caution.
The result was based on data from a trial with a moderate risk
of bias in which randomisation sequence, concealment allocation
and blinding of outcome assessor were unclear.
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The extent to which EMT contributes to healing in patients who
are also receiving pressure relief andmoist wound healing strategies
should be explored. The included trials, particularly Comorosan
1993, did not report severity of pressure ulcers and baseline com-
parisons adequately. Consequently, the results should be viewed as
unreliable until further research involving larger numbers of pa-
tients that can be considered alongside these trials becomes avail-
able.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is no reliable evidence of benefit for EMT in the treatment
of pressure ulcers. The small number of trials available for anal-
ysis (both with methodological limitations and small numbers of
participants) means that the possibility of benefit, or harm, of this
treatment cannot be ruled out.
Implications for research
Trials comparing EMT with sham therapy, or standard care, are
required to establish whether or not EMT improves the healing of
pressure ulcers. In addition, future trials should explore whether
particular subgroups of participants are more likely than others to
benefit from treatment with EMT and, if the treatment is shown
to be effective, to establish the point in a treatment regimen at
which it should be applied.
Both studies summarised in this review were small and had
methodological problems. Future trials will require:
1. participant numbers that ensure sufficient statistical power
to detect true treatment effects;
2. use of true randomisation with allocation concealment (e.g.
telephone randomisation, computer-generated codes);
3. measures to help ensure comparability of treatments at
baseline (e.g. stratification for ulcer size);
4. blinded outcome assessment;
5. use of objective outcome measurement (e.g. ulcer area,
complete healing rates); and
6. use of intention-to-treat analysis.
It is also recommended that studies should clearly describe the
frequency and duration of treatment, location of wounds and any
treatment(s) applied concurrently with the EMT.
Randomised controlled trials should be adequately reported. The
CONSORT2010 statement (Schulz 2010) lists 25 items that need
to be reported to show readers whether or not a trial is likely to
produce valid and reliable results. Further research into the rela-
tionship of EMT and pressure ulcer healing needs to be reported
in accordance with these guidelines.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Comorosan 1993
Methods RCT
Participants 30 (13 M;17 F) patients in an elderly care unit with either Stage II (16 participants) or
Stage III (14 participants) pressure ulcer. Ulcers were located on the buttocks (9), sacrum
(8), knee (6), coxal (2), back (3), heel(1) and leg (1).
Ulcer stages not defined. No report on patients’ mobility status
Interventions Group 1: (n = 20) Diapulse® plus conventional therapy*
Local application at a frequency of 600 pps, peak power 6 (117 V, 27.12 MHz), for 30
minutes 2 x daily. Hepatic application - 400 pps, peak power 4 (117 V, 27.12 MHz), 20
minutes 1 x daily, following initial Diapulse® treatment.
Group 2: (n = 5) sham Diapulse® plus conventional therapy*
Group 3: (n = 5) conventional therapy*
*Conventional therapy consisted of H2O2 cleansing and local applications of talcum
powder, methylene blue in solution and tetracycline ointments
Outcomes The outcomes assessed were proportion of ulcers healed and time to complete healing
PRIMARY OUTCOMES:
a) Number of ulcers healed at 5 weeks:
Group 1: 16/20
Group 2: 0/5
Group 3: 0/5
b) Rate of change in ulcer area: Not assessed in this study
c)Time to complete healing (weeks):
Stage II ulcers - achieved in (1 to 4); mean = 3.28 (no variance data reported)
Stage III ulcers - achieved in (2 to 8); mean = 4.87 (no variance data reported)
SECONDARY OUTCOMES:
d) Adverse effects: Reported no adverse effects
The trial had no loss to follow up
Notes No report of concurrent pressure relief used, such as support surfaces (bed, mattresses
and cushions). Locations of wounds were provided
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Comment: allocation to the 3 treatment groups was described
as “randomly organized” but there was no description of how
randomisation was achieved
Allocation concealment? Unclear Comment: no description of the process of allocation.
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Comorosan 1993 (Continued)
Blinding?
All outcomes
Unclear Comment: whilst “technician in charge , nor the clinician” were
reportedly blinded to Diapulse® and sham therapy, it would
not have been possible to blind the third group. There was also
no information on whether the outcome assessor was blinded
Incomplete outcome data addressed?
All outcomes
Yes Comment: reported no loss to follow up.
Free of selective reporting? Unclear Comment: outcomes to be assessed were not stated in the meth-
ods section of the article, therefore it was not clear whether the
trial included all planned outcomes. No access to trial protocol
Free of other bias? Unclear Themedianbaseline ulcer area varied between the 3 groups. This
difference may bias the evaluation in favour of the Diapulse®
group as this group has the lowest value (ulcer size)
Salzberg 1995
Methods RCT
Participants 30 (30 M) inpatients with spinal cord compression and a Stage II (n = 20) or Stage III (n
= 10) pressure ulcer. Grading defined by authors. Patients in both stage II and III were
allocated in equal numbers to the control and intervention groups
Baseline features: Reported - duration of ulcers prior to admission, degree of edema,
erythema, epithelialization, and ulcer size. Satge II patients there was no statistically
significant difference for the baseline parameters between the 10 in the EMT group and
the 10 in the sham group. But the randomisation process did not provide for an even
distribution of large pressure ulcers. No data were reported on baseline parameters from
the 10 patients with Satge II pressure ulcers
Interventions Group 1: (n = 15) electromagnetic energy at a frequency of 27.12 MHz, pulse repetition
80 to 600 pps, pulse width 65 microseconds, per pulse power range of 293 and 975 peak
watts - delivered through wound dressing, 30 minutes treatment 2 x daily for 12 weeks
Group 2: (n = 15) sham treatment as above.
All ulcers were dressed with moist saline gauze.
Outcomes The outcomes assessed were proportion of ulcers healed, percent of ulcers healed (defined
as reduction in wound surface area from the initial measurements) and time to complete
healing
PRIMARY OUTCOMES:
a) Number of ulcers healed within 1 week:
Stage II ulcer: Group 1 = 3/10; Group 2 = 0/10
Stage III ulcer: Group 1 = 3/5; Group 2 = 0/5
b) Percent reduction in ulcers surface area at 1 week:
Stage II ulcer (median): Group 1 = 84; Group 2 = 40
Stage III ulcer (mean): Group 2 = 70.6; Group 2 = 20.7
Percent overall reduction (SD): (this result was presented in the discussion section of the
paper)
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Salzberg 1995 (Continued)
Group 1: 77 (21)
Group 2: 40 (28)
c) Time to complete healing in days (median):
Stage II ulcers: Group 1 = 13; Group 2 = 31.5 (P < 0.001)
Stage III ulcers: not reported
SECONDARY OUTCOMES:
d) Adverse effects: No adverse effects reported
e) Cost: Suggested it would be more cost effective but did not provide data
The trial has 1 loss to follow up in the EMT group after week 1
Notes No report of concurrent pressure relief used, such as support surfaces (bed, mattresses
and cushions)
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Comment: allocation to the treatment groups was described as
“randomly assigned to receive therapy from either an active or
control sham” but there was no description of how randomisa-
tion was achieved
Allocation concealment? Unclear Comment: no description of the process of allocation
Blinding?
All outcomes
Unclear Comment: “Patients, staff and authors were blinded to the iden-
tity of the functioning unit” and the sham unit was identical in
operation, appearance, and sound to the active unit, the study
described that the outcomes were assessed by a single observer.
It was unclear if this assessor was blinded
Incomplete outcome data addressed?
All outcomes
Yes Comment: the trial had one loss to follow up after the outcome
was assessed, week 1 (the outcomes were reported at week 1)
Free of selective reporting? Unclear Comment: subset of patients with Stage II pressure ulcers less
than or equal to 60 cm2 and ulcer size more than 60 cm2 were
analysed separately. Stage II and Stage III patients were also
analysed separately. These analyses were not prespecified in the
methods section but may have been planned
Free of other bias? Unclear Comment: baseline data were provided only for patients with
Stage II but not for patients with Stage III pressure ulcers
Abbreviations:
H2O2 = hydrogen peroxide
n = number in sample group
pps = pulses per second
x = times
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Cooper-Vastola 1983 In the initial assessment, the title of article seemed relevant to the objective of the review. The abstract of the
study was unavailable. We requested the article via an interlibrary loan and direct contact with the author
and the journal publisher (Journal of American Paraplegia Society), all of which were unsuccessful. Therefore,
this study was excluded for pragmatic reasons because its content could not be verified firsthand
Goldin 1981 This study assessed wound healing of the donor site
Gupta 2009 Bates-Jensen wound assessment tool (also known as Pressure Sore Status Tool ) was used to assess the main
outcome measure. Data to validate the use of this tool to assess wound healing are still limited
Itoh 1991 Not a controlled trial
Seaborne 1996 Not a controlled trial. This study did not meet the inclusion criteria as it evaluated the effectiveness of pulsed
electromagnetic energy in the treatment of pressure ulcers using 4 different protocols (treatment plans)
Ullah 2007 This study did not meet the inclusion criteria as it examined micro current stimulation therapy and not
electromagnetic therapy
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D A T A A N D A N A L Y S E S
Comparison 1. Electromagnetic therapy versus sham electromagnetic therapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcers healed within 8
weeks of treatment
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
Comparison 2. Electromagnetic therapy versus standard therapy alone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcers healed within 8
weeks of treatment duration
1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
Comparison 3. Electromagnetic therapy versus sham electromagnetic therapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Healed ulcers at one week 1 30 Risk Ratio (M-H, Fixed, 95% CI) 7.0 [0.97, 50.38]
1.1 Stage II ulcers 1 20 Risk Ratio (M-H, Fixed, 95% CI) 7.0 [0.41, 120.16]
1.2 Stage III ulcers 1 10 Risk Ratio (M-H, Fixed, 95% CI) 7.0 [0.45, 108.26]
Comparison 4. Electromagnetic therapy versus sham electromagnetic therapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Percent reduction in wound
surface area at one week
1 30 Mean Difference (IV, Fixed, 95% CI) 37.0 [17.36, 56.64]
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Analysis 1.1. Comparison 1 Electromagnetic therapy versus sham electromagnetic therapy, Outcome 1
Pressure ulcers healed within 8 weeks of treatment.
Review: Electromagnetic therapy for treating pressure ulcers
Comparison: 1 Electromagnetic therapy versus sham electromagnetic therapy
Outcome: 1 Pressure ulcers healed within 8 weeks of treatment
Study or subgroup EMT Sham-EMT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Comorosan 1993 17/20 0/5 10.00 [ 0.70, 143.06 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 17 (EMT), 0 (Sham-EMT)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.001 0.01 0.1 1 10 100 1000
Favours Sham-EMT Favours EMT
Analysis 2.1. Comparison 2 Electromagnetic therapy versus standard therapy alone, Outcome 1 Pressure
ulcers healed within 8 weeks of treatment duration.
Review: Electromagnetic therapy for treating pressure ulcers
Comparison: 2 Electromagnetic therapy versus standard therapy alone
Outcome: 1 Pressure ulcers healed within 8 weeks of treatment duration
Study or subgroup EMT
Standard
therapy
alone Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Comorosan 1993 17/20 0/5 10.00 [ 0.70, 143.06 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 17 (EMT), 0 (Standard therapy alone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.001 0.01 0.1 1 10 100 1000
Favours std therapy alone Favours EMT
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Analysis 3.1. Comparison 3 Electromagnetic therapy versus sham electromagnetic therapy, Outcome 1
Healed ulcers at one week.
Review: Electromagnetic therapy for treating pressure ulcers
Comparison: 3 Electromagnetic therapy versus sham electromagnetic therapy
Outcome: 1 Healed ulcers at one week
Study or subgroup EMT Sham EMT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Stage II ulcers
Salzberg 1995 3/10 0/10 50.0 % 7.00 [ 0.41, 120.16 ]
Subtotal (95% CI) 10 10 50.0 % 7.00 [ 0.41, 120.16 ]
Total events: 3 (EMT), 0 (Sham EMT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.34 (P = 0.18)
2 Stage III ulcers
Salzberg 1995 3/5 0/5 50.0 % 7.00 [ 0.45, 108.26 ]
Subtotal (95% CI) 5 5 50.0 % 7.00 [ 0.45, 108.26 ]
Total events: 3 (EMT), 0 (Sham EMT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.39 (P = 0.16)
Total (95% CI) 15 15 100.0 % 7.00 [ 0.97, 50.38 ]
Total events: 6 (EMT), 0 (Sham EMT)
Heterogeneity: Chi2 = 0.0, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 1.93 (P = 0.053)
Test for subgroup differences: Chi2 = 0.0, df = 1 (P = 0.0), I2 =0.0%
0.001 0.01 0.1 1 10 100 1000
Favours sham EMT Favours EMT
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Analysis 4.1. Comparison 4 Electromagnetic therapy versus sham electromagnetic therapy, Outcome 1
Percent reduction in wound surface area at one week.
Review: Electromagnetic therapy for treating pressure ulcers
Comparison: 4 Electromagnetic therapy versus sham electromagnetic therapy
Outcome: 1 Percent reduction in wound surface area at one week
Study or subgroup EMT Sham EMT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Salzberg 1995 20 77 (21) 10 40 (28) 100.0 % 37.00 [ 17.36, 56.64 ]
Total (95% CI) 20 10 100.0 % 37.00 [ 17.36, 56.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.69 (P = 0.00022)
Test for subgroup differences: Not applicable
-500 -250 0 250 500
Favours Sham-EMT Favours EMT
A P P E N D I C E S
Appendix 1. Search strategy - second update 2008
For this second update of the review, we revised the search strategies and ran searches in the following databases to find randomised
controlled trials (RCTs) of electromagnetic therapy:
Cochrane Wounds Group Specialised Register (Searched 29/4/08 )
The Cochrane Central Register of Controlled Trials (CENTRAL) - The Cochrane Library Issue 2, 2008
Ovid MEDLINE 1966 to April Week 3 2008
Ovid EMBASE 1980 to 2008 Week 17
Ovid CINAHL 1982 to April Week 4 2008
The following search strategy was used in the Cochrane Central Register of Controlled Trials (CENTRAL):
#1 MeSH descriptor Electromagnetics explode all trees
#2 MeSH descriptor Electric Stimulation Therapy explode all trees
#3 (electromagnetic* or electrotherap*):ti,ab,kw
#4 (electric* NEXT current):ti,ab,kw
#5 ((direct or pulsed or alternating) NEXT current):ti,ab,kw
#6 (low NEXT intensity) or (low NEXT frequency):ti,ab,kw
#7 (high NEXT voltage):ti,ab,kw
#8 (“TENS” or “NMES”):ti,ab,kw
#9 (interferential NEXT therap*):ti,ab,kw
#10 (monophasic or galvanic):ti,ab,kw
#11 MeSH descriptor Diathermy explode all trees
#12 MeSH descriptor Microwaves explode all trees
#13 (diathermy or microwave*):ti,ab,kw
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#14 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR
#11 OR #12 OR #13)
#15 MeSH descriptor Pressure Ulcer explode all trees
#16 pressure NEXT (ulcer* or sore*):ti,ab,kw
#17 decubitus NEXT (ulcer* or sore*):ti,ab,kw
#18 (bed NEXT sore*) or bedsore:ti,ab,kw
#19 (#15 OR #16 OR #17 OR #18)
#20 (#14 AND #19)
The search strategy used in Ovid MEDLINE is available in Appendix 2. This strategy was adapted were appropriate for the Ovid
EMBASE andOvidCINAHL searches. TheOvidMEDLINE searchwas combined with theCochrane Highly Sensitive Search Strategy
for identifying randomized trials in MEDLINE: sensitivity- and precision-maximizing version (2008 revision); Ovid format (Higgins
2008). The EMBASE and CINAHL searches were combined with the trial filters developed by the Scottish Intercollegiate Guidelines
Network (SIGN 2008). There were no restrictions on the basis of language or date of publication.
Appendix 2. Ovid MEDLINE search strategy
1 exp Electromagnetics/
2 exp Electric Stimulation Therapy/
3 (electromagnetic$ or electrotherap$).ti,ab.
4 (electric$ adj stimulation).ti,ab.
5 (electric$ adj current).ti,ab.
6 ((direct or pulsed or alternating) adj current).ti,ab.
7 (low intensity or low frequency).ti,ab.
8 high voltage.ti,ab.
9 (TENS or NMES).ti,ab.
10 interferential therap$.ti,ab.
11 (monophasic or galvanic).ti,ab.
12 exp Diathermy/
13 exp Microwaves/
14 (diathermy or microwave$).ti,ab.
15 or/1-14
16 exp Pressure Ulcer/
17 (pressure adj (ulcer$ or sore$)).ti,ab.
18 (decubitus adj (ulcer$ or sore$)).ti,ab.
19 (bedsore$ or (bed adj sore$)).ti,ab.
20 or/16-19
21 15 and 20
Appendix 3. Ovid EMBASE search strategy
1 exp Electromagnetic Field/
2 exp Electrostimulation Therapy/
3 (electromagnetic$ or electrotherap$).ti,ab.
4 (electric$ adj stimulation).ti,ab.
5 (electric$ adj current).ti,ab.
6 ((direct or pulsed or alternating) adj current).ti,ab.
7 (low intensity or low frequency).ti,ab.
8 high voltage.ti,ab.
9 (TENS or NMES).ti,ab.
10 interferential therap$.ti,ab.
11 (monophasic or galvanic).ti,ab.
12 exp Diathermy/
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13 exp Microwaves/
14 (diathermy or microwave$).ti,ab.
15 or/1-14
16 exp Decubitus/
17 (pressure adj (ulcer$ or sore$)).ti,ab.
18 (decubitus adj (ulcer$ or sore$)).ti,ab.
19 (bedsore$ or (bed adj sore$)).ti,ab.
20 or/16-19
21 15 and 20
Appendix 4. EBSCO CINAHL search strategy
S21 S15 and S20
S20 S16 or S17 or S18 or S19
S19 TI decubitus or AB decubitus
S18 TI ( bed sore* or bedsore* ) or AB ( bed sore* or bedsore* )
S17 TI ( pressure ulcer* or pressure sore* ) or AB ( pressure ulcer* or pressure sore*)
S16 (MH “Pressure Ulcer”)
S15 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14
S14 TI ( diatherm* or microwave* ) or AB ( diatherm* or microwave* )
S13 (MH “Microwaves”)
S12 (MH “Diathermy+”)
S11 TI ( monophasic or galvanic ) or AB ( monophasic or galvanic )
S10 TI interferential therap* or AB interferential therap*
S9 TI ( TENS or NMES ) or AB ( TENS or NMES )
S8 TI high voltage or AB high voltage
S7 TI ( low intensity or low frequency ) or AB ( low intensity or low frequency )
S6 TI ( direct current or pulsed current or alternating current ) or AB ( direct current or pulsed current or alternating current )
S5 TI electric* current or AB electric* current
S4 TI electric* stimulation or AB electric* stimulation
S3 TI ( electromagnetic* or electrotherap* ) or AB ( electromagnetic* or electrotherap* )
S2 (MH “Electric Stimulation+”)
S1 (MH “Electromagnetics+”)
F E E D B A C K
Comment from Prof Comorosan September 2002
Summary
Your review analyzed two papers:
1. The effects of Diapulse Therapy on the healing of decubitus ulcers. Comoroson S, et al, Romanian Journal of Physiology;1993, 30,
41-5.
2. The effects of pulsed EM (Diapulse) on wound healing of pressure ulcers in the spinal cord injured patients. Salzberg CA. et al,
Wounds, 1995; 7,1, 11-16
The reviewer’s conclusions: “Neither study found a statistically significant difference between the healing rates of electromagnetic
therapy treated and control group patients. The results suggest no evidence of a benefit in using electromagnetic therapy to treat pressure
ulcers.”
This conclusion can not be correct.
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The first study (Comorosan 1993) I performed, and the results did in fact prove that Diapulse was a benefit in treating pressure
ulcers. The study was performed in accordance with the main request of the statistical studies: randomized groups and double blind
assessments. Moreover, it refers to a placebo group, compared to a control (conventional treatment) and an experimental one (Diapulse
and Conventional). After controlling the patients’ baseline, the null hypothesis is implicitly assumed: there will be no statistically
significant difference in the healing rates of patients receiving Diapulse therapy and those who receive placebo treatment. Evaluation of
the healing process is basically a qualitative medical assessment. Apart from size, no other quantitative (reliable) parameters are available.
Granulation percentage and epithelialization percentage were used to establish the classic scale of the healing process: excellent (healed),
very good (75-95% healed), good (50-75% healed), fair (25-50% healed), poor (less than 25% healed) and no improvement.
The results showed:
*In the conventional treatment group of 5 patients, 4 were rated unhealed and 1 less than 25%.
*In the conventional treatment and placebo Diapulse group of 5 patients, all were rated unhealed.
*In the Diapulse treated group of 20 patients, 18 were rated healed and 2 between 75-95%.
20 cases healed versus 10 unhealed, and the reviewers statement that there is not a significant difference and no evidence of benefit
from the electromagnetic therapy as one can see, is completely false and misleading.
I suggest you re-read the study, and correct the assumptions that are clearly ignoring clear-cut evidence. Based on the fact that an
evaluation was made after 5 weeks for the untreated Diapulse group and only 3 weeks for the Diapulse treated group, there was
significant benefit for the treated group.
In the second published study (Salzberg 1995), the authors concluded that, “Diapulse treatment significantly improved healing.” Strong
evidence of 30 spinal cord injured patients, treated successfully with Diapulse therapy is presented, again in a randomized double-
blind study. The baseline comparison of active Diapulse treatment versus placebo included each ulcer’s area, granulation percentage
and epithelialization percentage and was assessed by P-value, based on Mann-Whitney U tests. The authors used chi-square statistics
for categorical variables and t-test for normal distribution. For the entire group of 30 participants (20 stage II and 10 stage III), a clear
acceleration of wound healing was recorded.
After controlling the size, granulation and epithelialization, Diapulse treatment was found to be independently associated with percent
healed at one week (P = .002) and days to 100% healing (P = 0.007).
Somehow these data were ignored. Average percentage healing achieved at one week was 77% in the treated group (standard deviation
of 21%) versus 40% in the control group (standard deviation of 28%). This translates into an advantage of 3 to 1 for the active
Diapulse treated group. Again, ignoring this strong evidence, it was considered devoid of statistical significance and judged to be without
therapeutic merit.
Reply
Clinical decision making should give due weight to the research evidence, and that weight is determined by the volume and validity of
the research. The validity of a study is the extent to which its design and conduct are likely to prevent systematic errors or bias (Moher et
al, 1995). The criteria by which we assessed the validity of the primary research studies were pre-determined and peer reviewed, and are
also internationally accepted as important criteria by which to judge studies which aim to evaluate the clinical effects of interventions.
It is only by making rigorous, systematic assessment of the primary studies using criteria which have been determined a priori, and peer
reviewed, that we can minimise biases in the review process and be sure of identifying biases in the primary research which may lead
to invalid study results.
Generally, Cochrane Reviews tend to use the following broad criteria when assessing the internal validity of primary research studies
(usually RCTs):
• Protection against selection bias. An unpredictable allocation sequence must be generated e.g. by computer algorithm, and then
this sequence must be concealed from investigators who are enrolling patients. Knowledge of impending assignments can cause
selective enrolment of patients based on prognostic factors (Schulz et al). We therefore look to the trial report, and try to contact
investigators possible, to satisfy ourselves that there was true randomisation with allocation concealment. We also look for evidence
that the randomisation was successful in providing treatment groups which are balanced for important prognostic variables
(particularly baseline wound size in wound care studies, since wound size is known to predict time to heal).
• Protection against performance and detection bias. Performance bias occurs if any additional therapeutic interventions are
provided to one of the comparison groups. Blinding of patients and care providers helps prevent this kind of bias as well as reducing
the chance of differences in placebo responses between the groups. Detection bias may arise if knowledge of the patient assignment
can influence the measure of outcome.
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• Protection against attrition bias. Protocol deviations and loss to follow up may lead to exclusion of patients after they have been
allocated to treatment groups. Such ’lost’ patients are unlikely to be representative of all patients in a study as is also the case with
patients who do not ’adhere’ to the treatment. All patients should be analysed in the groups to which they were randomised on an
’intention-to-treat’ principle, so maintaining the randomisation and avoiding selection bias.
I would like to address our assessment of the internal validity of each of the papers in this review separately.
Comorosan et al. The effect of Diapulse therapy on the healing of decubitus pressure sores. Romanian Journal of Physiotherapy
1993,30,41-5.
Allocation to the three treatment groups in this study was described as randomised, however, we always look for a report of how this
randomisation was achieved in order to satisfy ourselves that selection bias was avoided. There was no such description nor explanation
of why there were 20 patients in the treatment group and five patients in each of the other therapy groups (obviously having unequal
treatment groups is a potentially valid approach but the allocation must be by a random process). The lack of a description of the
process of allocation also meant that we were unable to ascertain the degree of allocation concealment - which also protects against
selection bias (see above). However if you can provide us with information we will happily consider it.
During our validity assessment we also look for evidence of successful randomisation demonstrated by treatment groups which are
balanced at baseline for important prognostic factors such as wound size. Balanced allocation is frequently not achieved in studies as
small as this. Tests for ’significant’ differences are unhelpful in detecting baseline differences since a) they are underpowered, and b)
any differences have by definition arisen by chance if the patients were randomised. Whilst you did not report the average baseline
wound area in your paper, your recent correspondence has just prompted us to calculate it from Tables 2, 3 and 4 in your paper. The
median baseline ulcer area in the conventional treatment group was 3.9 cm2, 9 cm2 for the placebo treatment group, and 3.8 cm2 for
the electromagnetic treatment group. This baseline difference biases the evaluation in favour of the electromagnetic treatment group.
Percentage reduction in wound area is a measure that is itself biased in favour of the treatment group with the smallest average wound
size at baseline (since a change in area or volume will be a larger percentage of a smaller wound than a bigger wound), whereas actual
changes in size bias towards larger wounds. Time to complete wound healing is also a measure which would bias the study in favour
of the active treatment group since smaller wounds take longer to heal. The baseline inequalities in this study were not adjusted for in
the analysis.
Turning now to the possibility of performance and detection bias in this study, whilst clinicians and technicians were reportedly blinded
to Diapulse and sham Diapulse therapy, it would not have been possible to blind to the third therapy. Furthermore you do not state
who measured outcome (was it “the clinician”? Was there only one?). We are sure you are aware of the biases that can occur due to
lack of blinding. One of our major concerns with regard to detection bias is the lack of information reported on outcome assessment.
When an outcome relies on the judgement of a clinician (the primary outcome of this study was described as a “qualitative medical
assessment”) and that clinician is aware of the allocation of the patient being assessed then interpretation of the clinical findings may be
biased. Qualitative outcome measures such as this are of dubious validity anyway, especially when wound healing is relatively easy to
measure objectively (by measuring time to complete healing or serial measures of wound size). In our opinion a better approach would
be to present the actual reduction in area for each group along with confidence intervals to allow interpretation of the differences in
healing and the associated precision.
We would welcome any information that might give us further clarity on how the outcome assessment was undertaken. Incidentally we
are even more confused now given that your letter states that the evaluation was made after five weeks for the untreated Diapulse group
and only three weeks for the Diapulse treated group. How could these assessments have been made at different times if the assessor was
blinded? Why does the published paper state in the Abstract that there was is a maximum two-week treatment period; but in Tables 2,
3 and 4 that the duration of treatment was variously one, two, three, four, five, six and eight weeks!
From your data we calculated the relative risk (RR) for healing with Diapulse therapy. The Cochrane Collaboration recommends that
RRs are produced for dichotomous data whenever the event rate is greater than 30%. As you will be aware from reading the review
the RR for healing in your trial was 10 (95% CI 0.7 to 143.7). Whilst the result of this seems to favour the use of Diapulse therapy to
heal pressure ulcers, the wide confidence intervals, which include 1, indicate a lack of statistical significance. Unfortunately your trial
was extremely small, resulting in a lack of statistical power to detect a clinically important treatment effect as statistically significant
(the result for the main comparison are consistent with a RR anywhere between 0.7, i.e. in favour of conventional treatment, to 143.7
in favour of electromagnetic therapy). This together with the baseline difference in wound area means that whilst there may be a real
treatment effect your trial does not provide convincing evidence of it.
Salzberg CA et al. The effects of non-thermal pulsed electromagnetic energy (Diapulse) on wound healing of pressure sores in spinal
cord injured patients: A randomised double blind study. Wounds 1995; 7:1 11-16.
We were unable to obtain assurance of random sequence generation or allocation concealment from Salzberg’s written report. The
allocation process for people with Stage II ulcers did not result in a balanced allocation between the two treatment groups although
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this was corrected for in the analysis (whilst the statistical tests for differences were not significant the differences are not unimportant).
The low power of the study, again due to low sample size, is compounded by the separation of Stage II and Stage III patients which
is, in effect, a subgroup analysis. Such subgroup analyses should be pre-planned, and in this case it is severely underpowered, but is
the basis of the “statistically significant” difference in the original report. No baseline data were provided for patients with Stage III
pressure ulcers, therefore we were unable to judge the success of the randomisation. However, these patients account for 33% of the
patients in the study and they are effectively lost from the overall analysis. Readers cannot exclude chance or bias as possible causes
of the treatment difference. We calculated the RR of healing for people with Stage III pressure ulcers as 7 (95% CI 0.45 to 108.26).
Whilst this result is in the direction of benefit from Diapulse, there is no statistically significant difference.
The substantial questions about the internal validity of the two studies reviewed, and the small size of these studies, means that whilst
both studies show results in the same qualitative direction (that of benefit of electromagnetic therapy), it would have been wrong to
draw the conclusion that this is an effective treatment. This is clearly an important area for future high-quality research. Such research
should involve sufficient numbers of patients to ensure a realistic chance of detecting important treatment effects, and should avoid the
threats to validity so frequently observed in wound care trials. We would also urge that any further studies follow the internationally
respected CONSORT statement for the reporting of RCTs.
As I am sure you are aware, the systematic reviews undertaken by the Cochrane Collaboration use an internationally agreed process,
which includes pre-publication peer review of the review protocol and the finished review, and open peer review of the review at any
time after publication. This peer review did not identify similar concerns to yours. I am afraid we are unable to change the conclusions
of the Cochrane Review as requested.
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Date Event Description
20 September 2010 New search has been performed Third update. For this third update new searches were
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was completed. The reviewers’ conclusions remain un-
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The author team for the review has been revised
23Electromagnetic therapy for treating pressure ulcers (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
H I S T O R Y
Protocol first published: Issue 4, 1998
Review first published: Issue 4, 2000
Date Event Description
11 August 2009 Amended Contact details updated.
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